Brian G. Kingwell
Partner
- Year of Call, British Columbia (1993)
- Year of Call, Ontario (1993)
Areas of focus

Areas of focus
Brian Kingwell is a partner in the Vancouver office, practising in the firm's global Intellectual Property and Life Sciences groups.
For over 25 years, his practice has focused on patent prosecution, strategic patent portfolio counselling and due diligence in the areas of molecular biology, genomics, biochemistry, chemistry, chemical engineering and medical devices. Brian advises innovative clients across a range of sectors and industries, including health care, biotechnology, agriculture and cleantech.
He has wide-ranging experience in obtaining patents for innovative products, examples of which include: a novel family of heterocyclic antibiotics, the InsectSelect™ protein expression vector, high oleic acid brassica juncea plants, heavy metal waste remediation processes and Glybera®, the first human gene therapeutic approved in Europe. Brian is also the inventor of a patented medical device, the PeriPatch™ Sleeve.
The common thread across this range of experience is a creative and resourceful approach to maximizing the benefits of intellectual property for clients, helping clients to recognize risks and capitalize on opportunities.
Brian is a registered patent agent in both Canada and the United States.
Gowling WLG is an international law firm comprising the members of Gowling WLG International Limited, an English Company Limited by Guarantee, and their respective affiliates. Each member and affiliate is an autonomous and independent entity. Gowling WLG International Limited promotes, facilitates and co-ordinates the activities of its members but does not itself provide services to clients. Our structure is explained in more detail on our Legal Information page.
© 2026 Gowling WLG All rights reserved.